Related references
Note: Only part of the references are listed.Allicin pharmacology: Common molecular mechanisms against neuroinflammation and cardiovascular diseases
Feres Jose Mocayar Maron et al.
LIFE SCIENCES (2020)
Antihypertensive effects of allicin on spontaneously hypertensive rats via vasorelaxation and hydrogen sulfide mechanisms
Tianwei Cui et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Gating Properties of Mutant Sodium Channels and Responses to Sodium Current Inhibitors Predict Mexiletine-Sensitive Mutations of Long QT Syndrome 3
Gang Li et al.
FRONTIERS IN PHARMACOLOGY (2020)
Characterization of a novel LQT3 variant with a selective efficacy of mexiletine treatment
Hyun-Ji Kim et al.
SCIENTIFIC REPORTS (2019)
Long-term flecainide therapy in type 3 long QT syndrome
Ehud Chorin et al.
EUROPACE (2018)
Late sodium current associated cardiac electrophysiological and mechanical dysfunction
Shandong Yu et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2018)
Ion Channel Disorders and Sudden Cardiac Death
Anna Garcia-Elias et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Key Role of the Membrane Trafficking of Nav1.5 Channel Protein in Antidepressant-Induced Brugada Syndrome
Xi Chen et al.
FRONTIERS IN PHYSIOLOGY (2018)
Sodium channel biophysics, late sodium current and genetic arrhythmic syndromes
Karan R. Chadda et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2017)
MOLECULAR PATHOPHYSIOLOGY OF CONGENITAL LONG QT SYNDROME
M. S. Bohnen et al.
PHYSIOLOGICAL REVIEWS (2017)
Voltage-gated sodium channels assemble and gate as dimers
Jerome Clatot et al.
NATURE COMMUNICATIONS (2017)
Allicin inhibits transient outward potassium currents in mouse ventricular myocytes
Hong Cao et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2016)
Allitridi inhibits transient outward potassium currents in human atrial myocytes
Chun-Yu Deng et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2011)
SCN5A channelopathies - An update on mutations and mechanisms
Thomas Zimmer et al.
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY (2008)
Molecular basis of ranolazine block of LQT-3 mutant sodium channels: evidence for site of action
Sandra Fredj et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)